Victory Capital Management Inc Cytosorbents Corp Transaction History

Victory Capital Management Inc

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Nov 09, 2020	SELL	$7.37 - $11.54 $542,653 - $849,690	-73,630 Closed	0 $0
Q2 2020 Aug 07, 2020	BUY	$6.28 - $10.59 $432,064 - $728,592	68,800 Added 1424.43%	73,630 $729,000
Q1 2020 May 04, 2020	SELL	$3.77 - $7.73 $39,204 - $80,384	-10,399 Reduced 68.28%	4,830 $37,000
Q4 2019 Feb 06, 2020	SELL	$3.61 - $5.22 $17,833 - $25,786	-4,940 Reduced 24.49%	15,229 $59,000
Q4 2019 Feb 04, 2020	SELL	$3.61 - $5.22 $194 - $281	-54 Reduced 0.27%	20,169 $100,000
Q3 2019 Nov 12, 2019	BUY	$4.33 - $7.63 $87,565 - $154,301	20,223 New	20,223 $102,000

16.9M

10.1K

500

Ticker CTSO
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 43,577,400
Market Cap $51.9M
Description
Cytosorbents Corporation engages in the research, development, and commercialization of medical devices with its blood purification technology platform incorporating a proprietary adsorbent and porous polymer technology. Its flagship product is CytoSorb, an extracorporeal cytokine filter for adjunctive therapy in the treatment of sepsis, adjunct...

Get notified when there are updates to the investment portfolio of Victory Capital Management Inc, based on Form 13F filings with the SEC.

Stay updated on Victory Capital Management Inc with notifications on news.